AU2002359524A8 - P2x7 receptor antagonists - Google Patents

P2x7 receptor antagonists

Info

Publication number
AU2002359524A8
AU2002359524A8 AU2002359524A AU2002359524A AU2002359524A8 AU 2002359524 A8 AU2002359524 A8 AU 2002359524A8 AU 2002359524 A AU2002359524 A AU 2002359524A AU 2002359524 A AU2002359524 A AU 2002359524A AU 2002359524 A8 AU2002359524 A8 AU 2002359524A8
Authority
AU
Australia
Prior art keywords
receptor antagonists
antagonists
receptor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002359524A
Other versions
AU2002359524A1 (en
Inventor
Kenneth A Jacobson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
US Department of Health and Human Services
Original Assignee
US Department of Health and Human Services
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by US Department of Health and Human Services filed Critical US Department of Health and Human Services
Publication of AU2002359524A1 publication Critical patent/AU2002359524A1/en
Publication of AU2002359524A8 publication Critical patent/AU2002359524A8/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
    • C07D295/182—Radicals derived from carboxylic acids
    • C07D295/192—Radicals derived from carboxylic acids from aromatic carboxylic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/36—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • C07D217/26—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/645—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
    • C07F9/6509—Six-membered rings
    • C07F9/650952—Six-membered rings having the nitrogen atoms in the positions 1 and 4
AU2002359524A 2001-11-30 2002-11-27 P2x7 receptor antagonists Abandoned AU2002359524A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US33413001P 2001-11-30 2001-11-30
US60/334,130 2001-11-30
PCT/US2002/038126 WO2003047515A2 (en) 2001-11-30 2002-11-27 P2x7 receptor antagonists

Publications (2)

Publication Number Publication Date
AU2002359524A1 AU2002359524A1 (en) 2003-06-17
AU2002359524A8 true AU2002359524A8 (en) 2003-06-17

Family

ID=23305717

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002359524A Abandoned AU2002359524A1 (en) 2001-11-30 2002-11-27 P2x7 receptor antagonists

Country Status (2)

Country Link
AU (1) AU2002359524A1 (en)
WO (1) WO2003047515A2 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ533649A (en) * 2001-12-21 2006-01-27 King Pharmaceuticals Res & Dev Tyrosyl derivatives and their use as P2X7 receptor modulators
US20090124555A1 (en) * 2005-08-29 2009-05-14 Irma Bernatchez-Lemaire Use of histogranin and histogranin-like compounds as inhibitors of p2x7 receptor function and as anti-arthritic agents
DE602009000550D1 (en) 2008-03-25 2011-02-24 Affectis Pharmaceuticals Ag Novel P2X7R antagonists and their use
AU2010237302A1 (en) 2009-04-14 2011-12-01 Affectis Pharmaceuticals Ag Novel P2X7R antagonists and their use
JP2013521002A (en) 2010-03-05 2013-06-10 プレジデント アンド フェロウズ オブ ハーバード カレッジ Induced dendritic cell composition and use thereof
EA201201548A1 (en) 2010-05-14 2013-05-30 Эффектис Фармасьютиклз Аг NEW WAYS TO GET P2X7R ANTAGONISTS
WO2012110190A1 (en) 2011-02-17 2012-08-23 Affectis Pharmaceuticals Ag Novel p2x7r antagonists and their use
WO2012163792A1 (en) 2011-05-27 2012-12-06 Affectis Pharmaceuticals Ag Novel p2x7r antagonists and their use
WO2012163456A1 (en) 2011-05-27 2012-12-06 Affectis Pharmaceuticals Ag Novel p2x7r antagonists and their use

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5245034A (en) * 1988-12-26 1993-09-14 Kiroyoshi Hidaka Compound having vessel smooth muscle relaxation activity
JPH08119922A (en) * 1994-10-21 1996-05-14 Torii Yakuhin Kk Orth-pivaloyl-thyrosine derivative

Also Published As

Publication number Publication date
WO2003047515A3 (en) 2004-01-08
AU2002359524A1 (en) 2003-06-17
WO2003047515A2 (en) 2003-06-12

Similar Documents

Publication Publication Date Title
IL161329A0 (en) Benzamide and heteroarylamide as p2x7 receptor antagonists
AU2003261392A8 (en) M3muscarinic acetylcholine receptor antagonists
IL153308A0 (en) Thrombin receptor antagonists
EP1351933A4 (en) Il-8 receptor antagonists
HK1064100A1 (en) Adenosine a 2a receptor antagonists
IL152775A0 (en) Il-8 receptor antagonists
DZ3309A1 (en) Il-8 receptor antagonists
HK1063791A1 (en) Nk1 antagonists
IL151431A0 (en) Il-8 receptor antagonists
EP1359915A4 (en) Urotensin-ii receptor antagonists
EP1274415A4 (en) Il-8 receptor antagonists
IL151210A0 (en) Il-8 receptor antagonists
AU2002359524A8 (en) P2x7 receptor antagonists
GB0028104D0 (en) Bombesin receptor antagonists
EP1265905A4 (en) Il-8 receptor antagonists
GB0028146D0 (en) Bombesin receptor antagonists
EP1274428A4 (en) Il-8 receptor antagonists
EP1263427A4 (en) Il-8 receptor antagonists
EP1274413A4 (en) Il-8 receptor antagonists
IL156087A0 (en) Histamine receptor antagonists
PL370367A1 (en) Ccr-3 receptor antagonists v
EP1261329A4 (en) Il-8 receptor antagonists
IL158063A0 (en) Crf receptor antagonists
IL151434A0 (en) Il-8 receptor antagonists
GB0125183D0 (en) Receptor

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase